Literature DB >> 6496537

Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols.

D E Craven, D A Lichtenberg, T A Goularte, B J Make, W R McCabe.   

Abstract

The contamination rates of medication nebulizers inserted into mechanical ventilator circuits were studied. Semiquantitative techniques were used to sample the reservoir fluid from in-line nebulizers during the first 24 hours after a circuit change. In the initial survey, high levels of contamination (organism concentrations above 10(3)/ml) were present in 13 (68 percent) of the 19 nebulizer reservoirs, and bacterial aerosols were produced by 10 (71 percent) of 14 nebulizers. Gram-negative bacilli were the predominant organisms isolated. Nebulizer contamination originated primarily from reflux of contaminated condensate in the ventilator circuit. When nebulizers were cleaned after each treatment, a reduced rate of contamination was found. Small bacterial aerosols (less than 3 microns in size) were produced in vitro after inoculation of nebulizers with gram-negative bacilli in concentrations isolated from in-use nebulizers. Contaminated in-line medication nebulizers generate small-particle bacterial aerosols that may increase the risk of ventilator-associated pneumonia and therefore should be cleaned or disinfected after each treatment rather than every 24 hours.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6496537     DOI: 10.1016/0002-9343(84)90520-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  22 in total

Review 1.  Nosocomial pneumonia: epidemiology and infection control.

Authors:  D E Craven; K A Steger; L M Barat; R A Duncan
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 2.  Nebuliser therapy in the intensive care unit.

Authors:  M J O'Doherty; S H Thomas
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 3.  Nosocomial pneumonia in pediatric patients: practical problems and rational solutions.

Authors:  Heather J Zar; Mark F Cotton
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 5.  Nosocomial pneumonia in patients in intensive care units.

Authors:  S D Podnos; G B Toews; A K Pierce
Journal:  West J Med       Date:  1985-11

Review 6.  The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation.

Authors:  R J Estes; G U Meduri
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

Review 7.  Ventilator-associated pneumonia.

Authors:  Mv Pravin Charles; Arunava Kali; Joshy M Easow; Noyal Maria Joseph; M Ravishankar; Srirangaraj Srinivasan; Shailesh Kumar; Sivaraman Umadevi
Journal:  Australas Med J       Date:  2014-08-31

8.  Effect of negative air ions on the potential for bacterial contamination of plastic medical equipment.

Authors:  Simon J Shepherd; Clive B Beggs; Caroline F Smith; Kevin G Kerr; Catherine J Noakes; P Andrew Sleigh
Journal:  BMC Infect Dis       Date:  2010-04-12       Impact factor: 3.090

9.  Indigenous device for in circuit delivery of bronchodilator drugs through MDI.

Authors:  Balkar Singh; Nishkarsh Gupta; Bishnu Prasad Panigrahi; Deep Arora; Pradip Govil; Shibani Das; Manish Singh; Raj Tobin
Journal:  Indian J Anaesth       Date:  2010-05

10.  In vitro evaluation of aerosol bronchodilator delivery during mechanical ventilation: pressure-control vs. volume control ventilation.

Authors:  Dean R Hess; Christine Dillman; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2003-05-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.